Transient hyperglycemia in patients with acute myocardial infarction: Time to define optimal glucose levels

International Journal of Cardiology

Volumn 130, Issue 3, 2008, Pages 472-473

  Celik, Turgay ^a   Iyisoy, Atila ^a   Turhan, Hasan ^b   Isik, Ersoy ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b INONU UNIVERSITY   (Turkey)

Author keywords

Acute myocardial infraction; Hyperglycemia; Primary PCI

Indexed keywords

GLUCOSE; INSULIN; POTASSIUM;

ACUTE HEART INFARCTION; ARTICLE; BLOOD CLOT LYSIS; CARDIOGENIC SHOCK; CLINICAL FEATURE; DIABETES MELLITUS; DIET RESTRICTION; DISEASE EXACERBATION; DISEASE SEVERITY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEART FAILURE; HOSPITAL ADMISSION; HUMAN; HYPERGLYCEMIA; MORBIDITY; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; REVASCULARIZATION; RISK ASSESSMENT; ST SEGMENT ELEVATION; THROMBOSIS;

BLOOD GLUCOSE; HUMANS; HYPERGLYCEMIA; MYOCARDIAL INFARCTION; PROGNOSIS;

EID: 55549091089     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.06.076     Document Type: Article

References (15)

1. Lavi S., Kapeliovich M., Gruberg L., et al. Hyperglycemia during acute myocardial infarction in patients who are treated by primary percutaneous coronary intervention: impact on long-term prognosis. Int J Cardiol 123 (2008) 117-122
2. Nesto R.W., and Inzucchi S.E. Glycemic control for acute myocardial infarction in patients with and without diabetes mellitus. In: Rose B.D. (Ed). UpToDate (2006), UpToDate, Wellesley
3. Capes S.E., Hunt D., Malmberg K., and Gerstein H.C. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 355 (2000) 773-778
4. Kosiborod M., Rathore S.S., Inzucchi S.E., et al. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation 111 (2005) 3078-3086
5. Suleiman M., Hammerman H., Boulos M., et al. Fasting glucose is an important independent risk factor for 30-day mortality in patients with acute myocardial infarction: a prospective study. Circulation 111 (2005) 754-760
6. Cao J.J., Hudson M., Jankowski M., Whitehouse F., and Weaver W.D. Relation of chronic and acute glycemic control on mortality in acute myocardial infarction with diabetes mellitus. Am J Cardiol 96 (2005) 183-186
7. Timmer J.R., Ottervanger J.P., de Boer M.J., et al. Hyperglycemia is an important predictor of impaired coronary flow before reperfusion therapy in ST-segment elevation myocardial infarction. J Am Coll Cardiol 45 (2005) 999-1002
8. Pinto D.S., Skolnick A.H., Kirtane A.J., et al. U-shaped relationship of blood glucose with adverse outcomes among patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 46 (2005) 178-180
9. Malmberg K., Ryden L., Wedel H., et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J 26 (2005) 650-661
10. Malmberg K. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. BMJ 314 (1997) 1512-1515
11. Cheung N.W., Wong V.W., and McLean M. The Hyperglycemia: Intensive Insulin Infusion in Infarction (HI-5) study: a randomized controlled trial of insulin infusion therapy for myocardial infarction. Diabetes Care 29 (2006) 765-770
12. Mehta S.R., Yusuf S., Diaz R., et al. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. JAMA 293 (2005) 437-746
13. van der Horst I.C., Zijlstra F., van't Hof A.W., et al. Glucose-insulin-potassium infusion inpatients treated with primary angioplasty for acute myocardial infarction: the glucose-insulin-potassium study: a randomized trial. J Am Coll Cardiol 42 (2003) 784-791
14. Glucose-Insulin and potassium in STEMI patients: results of OASIS 6 study and a combined analysis with CREATE-ECLA trial. European Society of cardiology scientific congress (September 2006)
15. Timmer J.R., Svilaas T., Ottervanger J.P., et al. Glucose-insulin-potassium infusion in patients with acute myocardial infarction without signs of heart failure: the Glucose-Insulin-Potassium Study (GIPS)-II. J Am Coll Cardiol 47 (2006) 1730-1731